Nozu, Kandai http://orcid.org/0000-0002-0290-3137
Sako, Mayumi
Tanaka, Seiji
Kano, Yuji
Ohwada, Yoko
Morohashi, Tamaki
Hamada, Riku
Ohtsuka, Yasufumi
Oka, Masafumi
Kamei, Koichi
Inaba, Aya
Ito, Shuichi
Sakai, Tomoyuki
Kaito, Hiroshi
Shima, Yuko
Ishikura, Kenji
Nakamura, Hidefumi
Nakanishi, Koichi
Horinouchi, Tomoko
Konishi, Akihide
Omori, Takashi
Iijima, Kazumoto
Funding for this research was provided by:
Nippon Zenyaku Kogyo
Kobe University
Article History
Received: 1 August 2023
Accepted: 21 October 2023
First Online: 27 November 2023
Declarations
:
: Kandai Nozu received lecture fees from Chugai Pharmaceutical Co., Ltd. Mayumi Sako received consulting fees from Zenyaku Kogyo Co., Ltd. Koichi Kamei received grants from Chugai Pharmaceutical Co., Ltd. and Pfizer Inc., as well as lecture and/or consulting fees from Chugai Pharmaceutical Co., Ltd., Zenyaku Kogyo Co., Ltd., and Novartis Pharma K.K. Riku Hamada received lecture fees from Chugai Pharmaceutical Co., Ltd. and Novartis Pharma K.K. Yuko Shima received lecture fees from Novartis Pharma K.K. Yasufumi Ohtsuka received lecture fees from Chugai Pharmaceutical Co. Kenji Ishikura received grants from Novartis Pharma K.K., Zenyaku Kogyo Co., Ltd., and Chugai Pharmaceutical Co., as well as lecture fees from Chugai Pharmaceutical Co., Zenyaku Kogyo Co., and Novartis Pharma K.K. Koichi Nakanishi received lecture fees from Chugai Pharmaceutical Co., Ltd. and Novartis Pharma K.K. Kazumoto Iijima received a grant from Zenyaku Kogyo Co., Ltd., as well as lecture and/or consulting fees from Chugai Pharmaceutical Co., Ltd., Zenyaku Kogyo Co., Ltd., and Novartis Pharma K.K.
: This study was performed in accordance with the Declaration of Helsinki and approved by the Kobe University Hospital Institutional Review Board (no. 180035). This study was also approved by the ethics committee of each participating hospital. Informed consent was obtained from all individual participants and/or their guardians included in the study.